CD8A and myeloid sarcoma: Of the 19,312 cells analyzed from patients with MS, 4,107 were clustered as CD8+ T cells (21%); of 16,020 cells analyzed in IIH controls, 3,798 were in the CD8+ T cell clusters (24%).